- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Sartans market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period.
This report presents the market size and development trends by detailing the Sartans market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Sartans market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Sartans industry and will help you to build a panoramic view of the industrial development.
Sartans Market, By Type:
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Sartans Market, By Application:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Some of the leading players are as follows:
Astra Zeneca
Teva Pharmaceutical
Bristol-Myers Squibb
GSK
Pfizer
Jhonson and Johnson
Eli Lilly
Novartis
Merck
Bayer
Sanofi
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Sartans Market: Technology Type Analysis
-
4.1 Sartans Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Sartans Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Valsartan
4.3.2 Telmisartan
4.3.3 Losartan
4.3.4 Irbesartan
4.3.5 Azilsartan
4.3.6 Olmesartan
5 Sartans Market: Product Analysis
-
5.1 Sartans Product Market Share Analysis, 2018 & 2026
-
5.2 Sartans Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Sartans Market: Application Analysis
-
6.1 Sartans Application Market Share Analysis, 2018 & 2026
-
6.2 Sartans Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hypertension
6.3.2 Cardiovascular Diseases
6.3.3 Kidney Diseases
6.3.4 Other
7 Sartans Market: Regional Analysis
-
7.1 Sartans Regional Market Share Analysis, 2018 & 2026
-
7.2 Sartans Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Astra Zeneca
9.1.1 Astra Zeneca Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Teva Pharmaceutical
9.2.1 Teva Pharmaceutical Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 GSK
9.4.1 GSK Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Pfizer
9.5.1 Pfizer Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Jhonson and Johnson
9.6.1 Jhonson and Johnson Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Eli Lilly
9.7.1 Eli Lilly Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Novartis
9.8.1 Novartis Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Merck
9.9.1 Merck Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Bayer
9.10.1 Bayer Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Sanofi
9.11.1 Sanofi Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 77 Figures and 152 Tables)
Figure Valsartan Sartans market, 2015 - 2026 (USD Million)
Figure Telmisartan Sartans market, 2015 - 2026 (USD Million)
Figure Losartan Sartans market, 2015 - 2026 (USD Million)
Figure Irbesartan Sartans market, 2015 - 2026 (USD Million)
Figure Azilsartan Sartans market, 2015 - 2026 (USD Million)
Figure Olmesartan Sartans market, 2015 - 2026 (USD Million)
Figure Hypertension market, 2015 - 2026 (USD Million)
Figure Cardiovascular Diseases market, 2015 - 2026 (USD Million)
Figure Kidney Diseases market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Sartans market, by country, 2015 - 2026 (USD Million)
-
Table North America Sartans market, by type, 2015 - 2026 (USD Million)
-
Table North America Sartans market, by product, 2015 - 2026 (USD Million)
-
Table North America Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Sartans market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Sartans market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Canada Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Canada Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Europe Sartans market, by country, 2015 - 2026 (USD Million)
-
Table Europe Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Europe Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Europe Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Sartans market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Sartans market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Germany Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Germany Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Sartans market, by type, 2015 - 2026 (USD Million)
-
Table France Sartans market, by product, 2015 - 2026 (USD Million)
-
Table France Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Italy Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Italy Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Spain Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Spain Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sartans market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Sartans market, by type, 2015 - 2026 (USD Million)
-
Table China Sartans market, by product, 2015 - 2026 (USD Million)
-
Table China Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Japan Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Japan Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Sartans market, by type, 2015 - 2026 (USD Million)
-
Table India Sartans market, by product, 2015 - 2026 (USD Million)
-
Table India Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Sartans market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Sartans market, by application, 2015 - 2026 (USD Million)
-
Table MEA Sartans market, by country, 2015 - 2026 (USD Million)
-
Table MEA Sartans market, by type, 2015 - 2026 (USD Million)
-
Table MEA Sartans market, by product, 2015 - 2026 (USD Million)
-
Table MEA Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Sartans market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Sartans market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Sartans market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Sartans market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Sartans market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Astra Zeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GSK Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jhonson and Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-